Not Tagged
Not Tagged
['head and neck']
icymi: ninety-one percent of treatment-limited participants with recurrent or metastatic head and neck squamous cell carcinoma (#hnscc) experienced clinical benefit in a phase 2 clinical trial led by winship investigator nabil saba, md. #asco22 
As Georgia's NCI Comprehensive Cancer Center, we are at the forefront of cancer research, innovation, and discovery. Request patient appointment: (888) 946-7447